A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
通過6位分析師一窺Janux Therapeutics的專家展望
In the latest quarter, 6 analysts provided ratings for Janux Therapeutics (NASDAQ:JANX), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中，6位分析師爲Janux Therapeutics（納斯達克股票代碼：JANX）提供了評級，顯示了看漲和看跌的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $63.83, along with a high estimate of $100.00 and a low estimate of $48.00. Marking an increase of 130.68%, the current average surpasses the previous average price target of $27.67.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲63.83美元，最高估計爲100.00美元，低估值爲48.00美元。目前的平均價格上漲了130.68％，超過了之前的平均目標股價27.67美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細明細
A comprehensive examination of how financial experts perceive Janux Therapeutics is derived from...
對金融專家如何看待Janu...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。